Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Accenture
Covington
QuintilesIMS
Colorcon
Argus Health
Healthtrust
Mallinckrodt
Daiichi Sankyo
UBS

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020945

« Back to Dashboard

NDA 020945 describes NORVIR, which is a drug marketed by Abbott, Abbvie, and Abbvie Inc, and is included in five NDAs. It is available from five suppliers. There are nine patents protecting this drug and two Paragraph IV challenges. Additional details are available on the NORVIR profile page.

The generic ingredient in NORVIR is ritonavir. There are twenty-one drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ritonavir profile page.
Summary for 020945
Tradename:NORVIR
Applicant:Abbvie
Ingredient:ritonavir
Patents:3
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020945
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORVIR ritonavir CAPSULE;ORAL 020945 NDA AbbVie Inc. 0074-6633 N 0074-6633-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Jun 29, 1999TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:May 7, 2018Product Flag?Substance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Nov 22, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Sign UpPatent Expiration:Nov 22, 2020Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 020945

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie NORVIR ritonavir CAPSULE;ORAL 020945-001 Jun 29, 1999 ➤ Sign Up ➤ Sign Up
Abbvie NORVIR ritonavir CAPSULE;ORAL 020945-001 Jun 29, 1999 ➤ Sign Up ➤ Sign Up
Abbvie NORVIR ritonavir CAPSULE;ORAL 020945-001 Jun 29, 1999 ➤ Sign Up ➤ Sign Up
Abbvie NORVIR ritonavir CAPSULE;ORAL 020945-001 Jun 29, 1999 ➤ Sign Up ➤ Sign Up
Abbvie NORVIR ritonavir CAPSULE;ORAL 020945-001 Jun 29, 1999 ➤ Sign Up ➤ Sign Up
Abbvie NORVIR ritonavir CAPSULE;ORAL 020945-001 Jun 29, 1999 ➤ Sign Up ➤ Sign Up
Abbvie NORVIR ritonavir CAPSULE;ORAL 020945-001 Jun 29, 1999 ➤ Sign Up ➤ Sign Up
Abbvie NORVIR ritonavir CAPSULE;ORAL 020945-001 Jun 29, 1999 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Covington
US Army
Citi
Healthtrust
Cerilliant
Fish and Richardson
Chubb
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot